Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CV Sciences, Inc.CVSI · Entity 8316 | Director | June 02, 2021 | June 03, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CV Sciences, Inc.
Report date June 02, 2021 · Filed June 03, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.39 · Expires 2031-06-01 | Direct | 275,000 |
Reported balance
After 2021-06-02 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-06-02 · Grant · Acquired 275,000 · Balance 275,000 F1: The option is durational-based. All 275,000 option shares vest and become exercisable on April 15, 2022, provided, that there has not been a termination of service as of such date. In no event will any unvested portion of the option vest or become exercisable for any additional option shares after a termination of service. |
Filing footnotes · ownership attribution and instrument terms
F1: The option is durational-based. All 275,000 option shares vest and become exercisable on April 15, 2022, provided, that there has not been a termination of service as of such date. In no event will any unvested portion of the option vest or become exercisable for any additional option shares after a termination of service.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 02, 2021 Filed Jun 3, 2021 17:03 UTC | CV Sciences, Inc. CVSI · Entity 8316 | GrantStock Option (right to buy) · Derivative | 275,000 | $0.00 Strike: $0.39 | $0.00 |
DisclosureSEC source: 0001510964-21-000040 · wf-form4_162275414244753.xml · derivative · entry 1 BLAKE PAUL · CIK 0001209719 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,000 Underlying: Common Stock · 275,000 shares Expires 2031-06-01 F1 · derivative.exercise_date: The option is durational-based. All 275,000 option shares vest and become exercisable on April 15, 2022, provided, that there has not been a termination of service as of such date. In no event will any unvested portion of the option vest or become exercisable for any additional option shares after a termination of service. Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 20:55 UTC | CV Sciences, Inc. CVSI · Entity 8316 | GrantCommon Stock · Derivative | 150,000 | $0.00 Strike: $0.75 | $0.00 |
DisclosureSEC source: 0001510964-20-000058 · wf-form4_159252810555120.xml · derivative · entry 1 BLAKE PAUL · CIK 0001209719 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2030-06-15 F1 · derivative.exercise_date: The option is durational-based. 150,000 option shares vest and become exercisable on June 16, 2021, provided, however, that there has not been a termination of service as of such date. In no event will the option become exercisable for any additional option shares after a termination of service. Read SEC document |
| May 14, 2020 Filed May 15, 2020 17:20 UTC | CV Sciences, Inc. CVSI · Entity 8316 | PurchaseCommon Stock | 12,801 | $0.39 | $4,992.39 |
DisclosureSEC source: 0001510964-20-000043 · wf-form4_158957760086388.xml · nonDerivative · entry 1 BLAKE PAUL · CIK 0001209719 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,801 F1 · price: The reporting person undertakes to provide CV Sciences, Inc., any security holder of CV Sciences, Inc., or the staff of the Securities and Exchange Commission, upon request, the full information regarding the number of shares purchased at each seperate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.